Posts by Saman

Dr. Ross Brownson is the Lipstein Distinguished Professor of Public Health at Washington University in St. Louis. He studies the translation of evidence to public health practice and policy, with a content focus on environmental and policy determinants of chronic diseases. He directs the Prevention Research Center and co-directs the Washington University Implementation Science Center…

Steven M. Asch, MD, MPH, is a Vice-Chief for Research, Division of Primary Care and Population Health at Stanford University and the Associate Chief of Staff for Clinical Effectiveness at the Palo Alto VA. Dr. Asch also serves as an Associate Dean for Research, leading the KL2 Research Training Program, the Stanford Intermountain Fellowship, and…

Dr. Un is the Chief Medical Officer at Recovery Centers of America (RCA). He leads the development and implementation of the clinical behavioral health strategy for Recovery Center of America. Prior to joining RCA, he was the Chief Psychiatric Officer for Aetna/CVS where he led the design and oversaw the implementation of Aetna’s behavioral health…

Dr. Moberly is the senior program director of the Illinois Opioid Settlement Initiative at Advocates for Human Potential (AHP). Dr. Moberly has more than 20 years of experience in a wide range of healthcare settings. Her primary focus has been on creating strategies to strengthen state healthcare systems by improving access to comprehensive, integrated care…

Enola Proctor’s research is motivated by the question, how do we ensure that people receive the very best possible care? She is a major contributor to the advancement of D&I science. Dr. Proctor has both originated and stimulated the most influential work in the field from the categorization of implementation outcomes to the documentation of…

Charles’ primary focus is on identifying technology trends and new user experiences that will change the financial services landscape. His thesis investing has him focused on fintech, insurtech, and proptech opportunities with a crypto overlay to everything he evaluates. Charles’ public portfolio includes early-stage investments that have led to notable IPOs with DOMA (IPO 2021),…

A. Thomas McLellan is the founder and chairman of the board of directors at the Treatment Research Institute, a not-for-profit research and development institute in Philadelphia, Pennsylvania. McLellan was the principal developer of the Addiction Severity Index (ASI) and the Treatment Services Review (TSR). He has served as an adviser to many government and nonprofit…

Jeffrey De Flavio, MD, is the Founder of Groups: Recover Together, a national treatment provider for Opioid Use Disorder. With over 20,000 patients served in 2022, Groups’ unique clinical model and value-based contracting drive industry-leading clinical outcomes. Groups: Recover Together provides holistic treatment for Opioid Use Disorder across 142 offices in 18 states. The digital-hybrid…

Barbara Cimaglio is a national leader in the field of alcohol and drug abuse prevention, treatment, and recovery. Throughout her career she has led state efforts to strengthen and administer systems of care in Illinois, Oregon, and Vermont. In her role as single state agency substance use disorder director in each of these states, she…

Peter Friedmann, MD, is an established NIDA-funded addiction health services researcher, Chief Research Officer and Endowed Chair for Clinical Research at Baystate Health, and the Associate Dean for Research at the University of Massachusetts Medical School-Baystate. Dr. Friedmann is a primary care internist, addiction medicine clinician, and established substance abuse researcher who has published over…